Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Director/PDMR Notification

8 Apr 2021 07:00

RNS Number : 7513U
Aquis Exchange PLC
08 April 2021
Β 

8 April 2021

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

Β 

Director/PDMR Notification

Β 

Aquis Exchange PLC (AQX.L), the exchange services group, has been notified that Alasdair Haynes, CEO of the Company, sold 160,000 ordinary shares of 10p each in the Company ("Ordinary Shares") on 7 April 2021 at a price of Β£6.50 per Ordinary Share. Part of the sale is a result of his divorce settlement agreed in July 2017. Following this, Alasdair Haynes now holds 1,331,551 Ordinary Shares in the Company, representing 4.9% of the Company's issued share capital.

Β 

This announcement contains inside information under UK MAR.

Β 

Enquiries:

Β 

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

Belinda Keheyan, Head of Marketing

+44 (0) 7768 078 110

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

Chris Clarke

Edward Thomas

Kane Collings

Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Emma Gabriel (Corporate Broking)

Jeremy Grime (Specialist Sales)

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

aquis@almapr.co.uk

Kieran Breheny

Faye Calow

Β 

Notes to editors:

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's AutoritΓ© des MarchΓ©s Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go toΒ www.aquis.eu

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Alasdair Haynes

2

Reason for the notification

Β 

a)

Position/status

Β 

Chief Executive Officer

b)

Initial notification/ Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Β 

Aquis Exchange plc

b)

LEI

Β 

213800IXJSF5E1SIW150

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Identification code

Β 

Β 

Ordinary shares of 10 pence each

Β 

ISIN: GB00BD5JNK30

b)

Nature of the transaction

Β 

Sale of shares

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Β 

Β£6.50

Β 

160,000

Β 

Β 

d)

Aggregated information

-Aggregated volume

-Price

Β 

Β 

n/a - as above

e)

Date of the transaction

Β 

07/04/2021

f)

Place of the transactionΒ 

London Stock Exchange

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFLASIIDIIL
Date   Source Headline
15th Jan 20253:25 pmRNSForm 8.3 - Aquis Exchange plc
15th Jan 20253:06 pmRNSForm 8.3 - Aquis Exchange plc
15th Jan 202511:33 amRNSForm 8.5 (EPT/RI) - Aquis Exchange Plc
15th Jan 202511:11 amRNSForm 8.3 - Aquis Exchange Plc
14th Jan 202510:05 amRNSForm 8.3 - Aquis Exchange PLC
14th Jan 202510:00 amRNSForm 8.3 - Aquis Exchange PLC
8th Jan 202512:00 pmRNS-RUpdate on Joint Venture
7th Jan 20253:30 pmRNSForm 8.3 - AQX LN
7th Jan 20251:56 pmRNSForm 8.3 - Aquis Exchange PLC
3rd Jan 20253:30 pmRNSForm 8.3 - AQX LN
3rd Jan 202512:48 pmRNSForm 8.3 - Aquis Exchange PLC
3rd Jan 20259:40 amRNSForm 8.5 (EPT/RI)
2nd Jan 20251:58 pmRNSForm 8.3 - Aquis Exchange PLC
30th Dec 20249:41 amRNSForm 8.5 (EPT/RI)
24th Dec 202410:45 amRNSForm 8.5 (EPT/RI) - Aquis Exchange Plc
23rd Dec 202411:22 amRNSForm 8.3 - Aquis Exchange plc
23rd Dec 202411:21 amRNSForm 8.3 - Aquis Exchange PLC
20th Dec 202411:37 amRNSResults of voting at Court Meeting and GM
18th Dec 202410:10 amRNSForm 8.5 (EPT/RI)
17th Dec 202410:09 amRNSForm 8.5 (EPT/RI)
16th Dec 20241:38 pmRNSForm 8.5 (EPT/RI) - Aquis Exchange Plc
16th Dec 20241:38 pmRNSForm 8.5 (EPT/RI) - Aquis Exchange Plc
16th Dec 202411:01 amRNSForm 8.3 - Aquis Exchange plc
16th Dec 20249:52 amGNWForm 8.5 (EPT/RI) - Aquis Exchange plc
13th Dec 202410:36 amGNWForm 8.5 (EPT/RI)-Aquis Exchange plc
13th Dec 202410:06 amRNSForm 8.5 (EPT/RI)
12th Dec 202410:13 amRNSForm 8.5 (EPT/RI)
10th Dec 202411:51 amRNSForm 8.3 - Aquis Exchange PLC
10th Dec 202410:54 amRNSForm 8.5 (EPT/RI)
9th Dec 202411:37 amRNSForm 8.3 - Aquis Exchange plc
9th Dec 20248:10 amGNWForm 8.5 (EPT/RI)-Aquis Exchange plc
6th Dec 20249:50 amRNSForm 8.5 (EPT/RI)
6th Dec 20247:32 amRNSForm 8.3 - Aquis Exchange plc
5th Dec 20248:20 amGNWForm 8.5 (EPT/RI) - Aquis Exchange plc
4th Dec 20245:11 pmRNSRule 2.9 Announcement
2nd Dec 202410:42 amRNSForm 8.5 (EPT/RI)
29th Nov 20249:47 amRNSForm 8.5 (EPT/RI)
28th Nov 202410:12 amRNSForm 8.5 (EPT/RI)
27th Nov 20242:12 pmEQSForm 8.3 - Aquis Exchange PLC
27th Nov 202411:26 amRNSPublication of Scheme Document
27th Nov 202410:39 amRNSForm 8.5 (EPT/RI)
26th Nov 202410:24 amRNSForm 8.3 - Aquis Exchange PLC
26th Nov 20249:49 amRNSForm 8.5 (EPT/RI)
26th Nov 20249:34 amGNWForm 8.5 (EPT/RI) - Aquis Exchange plc
25th Nov 202412:10 pmRNSForm 8.3 - Aquis Exchange PLC
25th Nov 202410:21 amRNSForm 8.5 (EPT/RI)
22nd Nov 202411:08 amRNSForm 8.5 (EPT/RI)
21st Nov 20242:16 pmBUSForm 8.3 - Aquis Exchange plc
21st Nov 202412:10 pmRNSForm 8.3 - Aquis Exchange PLC
21st Nov 202411:42 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.